Medically reviewed on September 17, 2018
Scientific Name(s): Bupleurum falcatum L., (synonym Bupleurum chinense DC. and Bupleurum scorzonerifolium Willd.). Family: Apiaceae (carrots). Synonym: Umbelliferae
Common Name(s): Beichaihu , Bupleuri Radix , bupleurum root , Chai-hu , Chaihu (Chinese), hare's ear root , Radix Bupleuri , Saiko (Japanese) , thorowax , thorow wax .
Bupleurum is being investigated for its antipyretic, immunomodulatory, GI tract, and hepatoprotective effects, as well as its potential in the prevention and treatment of cancers. Clinical trials are generally lacking.
No clinical trials exist.
Contraindications have not been identified.
Information regarding safety and efficacy in pregnancy and lactation is lacking.
None well documented.
Mild lassitude, sedation, and drowsiness. Large doses may increase flatulence and bowel movements. Allergy to injected bupleurum has been reported.
The toxicity profile appears to be low; however, information is limited.
Bupleurum is a perennial herb that grows mainly in China, but is also cultivated in other areas. The plant grows to approximately 1 m in height and requires abundant sun to flourish. The leaves are long and sickle-shaped with parallel veining. Terminal clusters of small, yellow flowers appear in autumn. The long cone or column-shaped, single or branched root is 10 to 20 cm in length and 0.5 to 1.5 cm in diameter. It is light brown to brown, may be wrinkled, and is easily broken. 1 , 2 , 3
More than 20 species have been described in the genus Bupleurum , including a toxic species, Bupleurum longiradiatum , found in northeast China, and Bupleurum kaoi , which is indigenous to Taiwan. 3 , 4 , 5 , 6 The root of B. chinense DC. is considered to be the genuine Chaihu, but other species have been included in the Pharmacopoeia of the People's Republic of China since 1963, including Bei Chaihu and Nan Chaihu (referring to northern and southern thorowax root). B. falcatum is used in Japan. 4 Confusion exists regarding the species called B. scorzonerifolium Willd., which may be the same as B. falcatum L. var scorzonerifolium . 3
Bupleurum is a traditional Chinese herb dating back to the first century BC and is one of the most commonly used herbs in traditional Chinese medicine. It forms an integral part of many Kampo medicines (the Japanese adaptation of traditional Chinese medicine), including shosaikoto, daisaikoto, saikokeishito, hochuekkito, saibokuto, and saireito. 4 , 7 One of China's harmony herbs purported to affect organs and energy in the body, bupleurum has been used as a liver tonic, with spleen and stomach toning properties. The plant has also been used to promote perspiration and treat fever, flu, distending pain in the chest, and menstrual disorders. 3 , 4 , 7
Bupleurum contains triterpene saponins or saikosides, also known as saikosaponins. 4 Levels of these saikosaponins vary widely between species (ie, B. falcatum 2% to 8% and B. chinense 1.7%) and between wild and cultivated species. Levels also depend upon growing conditions. 4 , 7 Root parts of bupleurum have been analyzed, resulting in the discovery of many saikosaponins. 4 , 9 , 10 Saponins, along with 8 flavonoid compounds and indole alkaloid glucosides, have been found in the aerial parts of 6 species. 11 , 12 Saikogenins A, B, C, and D are also present in the plant. Spinasterol, stigmasterol, and rutin have been found, as well as pectin-like polysaccharides (bupleurans). 13 The essential oil contains 14 different chemical compounds; Li05b and long-chain unsaturated fatty acids have been described. 5 Chemical constituents have been assayed by high performance liquid chromatography, capillary gas chromatography, and capillary zone electrophoresis. 3 , 4 , 5 , 10 , 12 , 14
Uses and PharmacologyAntipyretic effects
Oral decoctions of bupleurum, subcutaneous injection of the root extract, and oral saikosaponins have shown antipyretic effects in rats and rabbits. 3 Nasal gel and nasal spray made from the essential oil of bupleurum reduced fever in rats and rabbits in a dose-dependent manner. 15 , 16Clinical data
Radix Bupleuri reduces fever in influenza, the common cold, malaria, and pneumonia, with antipyretic effects in the majority of patients. 3 However, clinical trials have not been reported in peer-reviewed journals.Cancer
The saponin fraction of B. kaoi , the acetone extract of the roots of B. scorzonerifolium , a polysaccharide bupleuran from the roots of B. falcatum , a novel lignin (isochaihulactone), and the extract from the root of B. longiradiatum have all been evaluated for antiproliferative and apoptotic effects. 17 , 18 , 19 , 20 , 21 , 22 , 23Animal data
Limited in vivo animal experiments have been conducted. Studies in mice with lung adenocarcinoma showed a dose-dependent antiproliferative effect on tumor growth for B. scorzonerifolium extracts. 17 , 22 Extracts from the roots of B. longiradiatum were antiangiogenic in vitro, but they were not effective against lung tumors in mice and were fatally toxic at higher dosages. 23Clinical data
Clinical trials are lacking.GI/Gastric ulcer
In animal experiments, the polysaccharide bupleurans and saikosaponins reduced the effect of induced gastric ulcers and increase healing rates and were comparable with sucralfate. Suggested mechanisms of action include the reinforcement of the gastric mucosal barrier and an antisecretory action on acid and pepsin. 3 , 24 , 25 , 26 An ethanol extract of the aerial parts of the plant exhibited anti- H. pylori action in vitro. 27Clinical data
Clinical trials are lacking.Hepatoprotective effects
Saikosaponins and root and leaf extracts have demonstrated protective effects on acetaminophen and carbon tetrachloride-induced hepatic injury in rats. Most, but not all, experiments have shown positive effects on ALT and AST as well as histological changes, such as cell membrane malfunctions and cell death. The effects are attributed mainly to decreased oxidative stress. 3 , 6 , 28 , 29 , 30 , 31 , 32 , 33Clinical data
High-quality clinical trials are lacking. Intravenous injection of bupleurum led to beneficial therapeutic outcomes in 100 cases of infectious hepatitis in adults and children. 34Immune system modulation/inflammation
In vitro studies have shown both up- and down-regulation effects of root extracts, polysaccharide bupleurans, and individual saikosaponins, especially saikosaponin D, on the immune system. Increased antibody response, induction of type 1 interferons, and up-regulation of macrophages have been demonstrated. 3 , 8 , 35 , 36 , 37 , 38 Bidirectional effects on T lymphocytes have also been demonstrated, possibly a dose-dependent effect. 3 , 8 , 35 , 39 , 40 , 41 Anticomplementary effects by polysaccharide extracts of Bupleurum smithii roots 42 and inhibition of cyclooxygenase and lipoxygenase by the aerial part of Bupleurum fruitcescens have been demonstrated. 43Animal data
Rat paw edema experiments have been conducted using crude extracts of B. falcatum , purified saponins 3 and 7, and some saikosaponins A and D. The anti-inflammatory effect was similar to that of prednisolone, 3 but not of dexamethasone. 44 Saikosaponin C prevented nephritis in mice treated with nephrotoxic serum, but it did not prevent the formation or deposition of immune complex, suggesting an upregulation of enzymes or mechanisms that digest and clear the immune complexes. 45Clinical data
Clinical trials are lacking. 13Other uses
Animal experiments suggest bupleurum extracts and sapogenin A may possess analgesic effects. 3Antiviral
Bupleurum inactivated enveloped viruses, including measles and herpes, but had no effect on nonenveloped viruses, such as polio. 46 Saikosaponins inhibit coxsackie B virus, 36 and saikosaponin B inhibited the human coronavirus, which is responsible for severe acute respiratory syndrome. 47Asthma
Saikosaponin A reduced antigen challenge-induced bronchoconstriction in experiments conducted on guinea pigs. 48Cardiac
The chloroform extract of roots of Bupleurum fruticosum exerted vaso-relaxant effects on rat aorta. 49Sedation
Saikosaponins, especially saiksaponin A and saikogenin A, inhibited rod climbing in mice and antagonized caffeine and methamphetamine. 34
Dosage of Radix Bupleuri is 3 to 9 g/day 3 ; however, no clinical trials have been performed to validate this range as safe or effective.
Information regarding safety and efficacy in pregnancy and lactation is lacking.
Antiaggregation effects on platelets have been demonstrated in vitro by the lactone bupleurumin extracted from the aerial parts of B. falcatum . 50 Therefore, potentiation of thrombolytic and antiaggregating medicines is theoretically possible. Saikosaponins antagonized the stimulatory effects of caffeine and methamphetamine in mice; synergism with CNS depressants is possible. 3 , 34
Bupleuri Radix forms an integral part of many Kampo medicines (eg, shosaikoto, daisaikoto, saikokeishito, hochuekkito, saibokuto, saireito) for which interactions have been reported. Preparations include combinations of bupleurum with glycyrrhiza, scutellaria root, ginseng, jujube fruit, astragalus root, magnolia bark, alisma rhizome, and rhubarb. 7 Assigning causality in reported drug interactions to individual plant components is difficult.
Bupleurum has produced mild lassitude, sedation, and drowsiness in some patients. 3 Large doses have been reported to increase flatulence and bowel movements. 3 Allergy to injected bupleurum has been reported. 34
Bupleuri Radix forms an integral part of many combination preparations for which adverse reactions have been reported. Assigning causality in reported drug interactions to individual plant components is difficult. 51 Adult respiratory distress syndrome has been reported, with one case attributed to bupleurum. 52
Limited pharmacokinetic information is available in humans. Crude saikosaponins show low-medium toxicity in mice (oral median lethal dose = 4.7 g/kg and intramuscular median lethal dose = 112 mg/kg). 8 Methanolic extracts of B. falcatum have not shown mutagenic effects in most modified Ames Salmonella tests; however, one report found enhanced mutagenic activity with a hot-water extract of B. falcatum . 3
Bibliography1. USDA, NRCS. 2009. The PLANTS Database ( http://plants.usda.gov , 27 April 2009). National Plant Data Center, Baton Rouge, LA 70874-4490 USA.
2. Chevallier, A. The Encyclopedia of Medicinal Plants. New York, NY: DK Publishing; 1996: 68.
3. Radix Bupleuri. In: WHO monographs on selected medicinal plants . Vol 1. Geneva, Switzerland: World Health Organization; 1999: 67-76.
4. Tian RT, Xie PS, Liu HP. Evaluation of traditional Chinese herbal medicine: Chaihu (Bupleuri Radix) by both high-performance liquid chromatographic and high-performance thin-layer chromatographic fingerprint and chemometric analysis. J Chromatogr A . 2009;1216(11):2150-2155.
5. Li XQ, Song AH, Li W, Chen XH, Bi KS. Analysis of the fatty acid from Bupleurum Chinense DC in China by GC-MS and GC-FID. Chem Pharm Bull (Tokyo) . 2005;53(12):1613-1617.
6. Liu CT, Chuang PT, Wu CY, Weng YM, Chen W, Tseng CY. Antioxidative and in vitro hepatoprotective activity of Bupleurum kaoi leaf infusion. Phytother Res . 2006;20(11):1003-1008.
7. Ikegami F, Sumino M, Fujii Y, Akiba T, Satoh T. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Hum Exp Toxicol . 2006;25(8):481-494.
8. Sun HX. Haemolytic activities and adjuvant effect of Bupleurum chinense saponins on the immune responses to ovalbumin in mice. Vaccine . 2006;24(9):1324-1331.
9. Jing H, Jiang Y, Luo S. Chemical constituents of the roots of Bupleurum longicaule Wall. ex DC. var. franchetii de Boiss and B. chaishoui Shan et Sheh [in Chinese]. Zhongguo Zhong Yao Za Zhi . 1996;21(12):739-741, 762.
10. Lin X, Xue L, Zhang H, Zhu C. Determination of saikosaponins a, c, and d in Bupleurum Chinese DC from different areas by capillary zone electrophoresis. Anal Bioanal Chem . 2005;382(7):1610-1615.
11. Luo S, Jin H. Chemical constituents of the aerial parts of six species of Bupleurum genus medicinally used in south-west region of China [in Chinese]. Zhongguo Zhong Yao Za Zhi . 1991;16(6):353-356, 383.
12. Kuang H, Sun S, Yang B, Xia Y, Feng W. New megastigmane sesquiterpene and indole alkaloid glucosides from the aerial parts of Bupleurum chinense DC. Fitoterapia . 2009;80(1):35-38.
13. Bone K. Bupleurum: a natural steroid effect. Can J Herbalism . 1996;17(3):22-25,41.
14. Li X, Jia Y, Song A, Chen X, Bi K. Analysis of the essential oil from radix bupleuri using capillary gas chromatography. Yakugaku Zasshi . 2005;125(10):815-819.
15. Xie Y, Lu W, Cao S, Jiang X, Yin M, Tang W. Preparation of bupleurum nasal spray and evaluation on its safety and efficacy. Chem Pharm Bull (Tokyo) . 2006;54(1):48-53.
16. Cao SL, Chen E, Zhang QZ, Jiang XG. A novel nasal delivery system of a Chinese traditional medicine, Radix Bupleuri, based on the concept of ion-activated in situ gel. Arch Pharm Res . 2007;30(8):1014-1019.
17. Cheng YL, Lee SC, Lin SZ, et al. Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo. Cancer Lett . 2005;222(2):183-193.
18. Hsu YL, Kuo PL, Weng TC, Yen MH, Chiang LC, Lin CC. The antiproliferative activity of saponin-enriched fraction from Bupleurum Kaoi is through Fas-dependent apoptotic pathway in human non-small cell lung cancer A549 cells. Biol Pharm Bull . 2004;27(7):1112-1115.
19. Kang SJ, Lee YJ, Kim BM, et al. Effect of Bupleuri Radix extracts on the toxicity of 5-fluorouracil in HepG2 hepatoma cells and normal human lymphocytes. Basic Clin Pharmacol Toxicol . 2008;103(4):305-313.
20. Ohtsu S, Izumi S, Iwanaga S. Ohno N, Yadomae T. Analysis of mitogenic substances in Bupleurum chinense by ESR spectroscopy. Biol Pharm Bull . 1997;20(1):97-100.
21. Cheng YL, Chang WL, Lee SC, et al. Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci . 2003;73(18):2383-2394.
22. Chen YL, Lin SZ, Chang JY, et al. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. Biochem Pharmacol . 2006;72(3):308-319.
23. You YJ, Lee IS, Kim Y, Bae KH, Ahn BZ. Antiangiogenic activity of Bupleurum longiradiatum on human umbilical venous endothelial cells. Arch Pharm Res . 2002;25(5):640-642.
24. Matsumoto T, Sun XB, Hanawa T, Kodaira H, Ishii K, Yamada H. Effect of the antiulcer polysaccharide fraction from Bupleurum falcatum L. on the healing of gastric ulcer induced by acetic acid in rats. Phytother Res . 2002;16(1):91-93.
25. Amagaya S, Ishige A, Takeda S, et al. General pharmacological properties of Tj-9 extract. Phytomedicine . 1998;5(3):165-175.
26. Hung CR, Wu TS, Chang TY. Comparison between the effects of crude saikosaponin and 16, 16-dimethyl prostaglandin E2 on tannic acid-induced gastric mucosal damage in rats. Chin J Physiol . 1993;36(4):211-217.
27. Li Y, Xu C, Zhang Q, Liu JY, Tan RX. In vitro anti- Helicobacter pylor i action of 30 Chinese herbal medicines used to treat ulcer diseases. J Ethnopharmacol . 2005;98(3):329-333.
28. Chiu HF, Lin CC, Yang CC, Yang F. The pharmacological and pathological studies on several hepatic protective crude drugs from Taiwan (I). Am J Chin Med . 1988;16(3-4):127-137.
29. Lin CC, Chiu HF, Yen MH, Wu CC, Chen MF. The pharmacological and pathological studies on Taiwan folk medicine (III): the effects of Bupleurum kaoi and cultivated Bupleurum falcatum var. komarowi. Am J Chin Med . 1990;18(3-4):105-112.
30. Lin CC, Yen MH, Chiu HF, Chang CH. The pharmacological and pathological studies on Taiwan folk medicine (IV): the effects of echinops grijisii and e. Latifolius. Am J Chin Med . 1990;18(3-4):113-120.
31. Yen MH, Lin CC, Chuang CH, Liu SY. Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of “xiao-chai-hu-tang” prepared using three different Bupleurum species. J Ethnopharmacol . 1991;34(2-3):155-165.
32. Wang BJ, Liu CT, Tseng CY, Wu CP, Yu ZR. Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO(2) on CCl(4)-induced liver damage. Food Chem Toxicol . 2004;42(4):609-617.
33. Wu SJ, Lin YH, Chu CC, Tsai YH, Chao JC. Curcumin or saikosaponin a improves hepatic antioxidant capacity and protects against CCl4-induced liver injury in rats. J Med Food . 2008;11(2):224-229.
34. Chang H, But PP, eds. Pharmacology and Applications of Chinese Materia Medica . Yao S, Wang L, Shem CY, trans-eds. Singapore; Philadelphia, PA: World Scientific; 1987.
35. Wong VK, Zhou H, Cheung SS, Li T, Liu L. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation. J Cell Biochem . 2009;107(2):303-315.
36. Cheng PW, Chiang LC, Yen MH, Lin CC. Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression. Food Chem Toxicol . 2007;45(1):24-31.
37. Matsumoto T, Guo YJ, Ikejima T, Yamada H. Induction of cell cycle regulatory proteins by murine B cell proliferating pectic polysaccharide from the roots of Bupleurum falcatum L. Immunol Lett . 2003;89(2-3):111-118.
38. Matsumoto T, Moriya M, Sakurai MH, Kiyohara H, Tabuchi Y, Yamada H. Stimulatory effect of a pectic polysaccharide from a medicinal herb, the roots of Bupleurum falcatum L., on G-CSF secretion from intestinal epithelial cells [published correction appears in Int Immunopharmacol . 2008;8(12):1713]. Int Immunopharmacol . 2008;8(4):581-588.
39. Chang WL, Chiu LW, Lai JH, Lin HC. Immunosuppressive flavones and lignans from Bupleurum scorzonerifolium . Phytochemistry . 2003;64(8):1375-1379.
40. Sun Y, Cai TT, Zhou XB, Xu Q. Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis. Int Immunopharmacol . 2009;9(7-8):978-983.
41. Leung CY, Liu L, Wong RN, Zeng YY, Li M, Zhou H. Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor. Biochem Biophys Res Commun . 2005;338(4):1920-1927.
42. Xu H, Zhang Y, Zhang J, Chen D. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii . Int Immunopharmacol . 2007;7(2):175-182.
43. Prieto JM, Giner RM, Recio MC, Máñez S, Rios JL. Dual inhibition of cyclooxygenase-1 and 5-lipoxygenase by aerial part of Bupleurum fruticescens methanol extract. Fitoterapia . 2004;75(2):179-186.
44. Navarro P, Giner RM, Recio MC, Máñez S, Cerda-Nicolas M, Rios JL. In vivo anti-inflammatory activity of saponins from Bupleurum rotundifolium . Life Sci . 2001;68(10):1199-1206.
45. Chen SM, Sato N, Yoshida M, Satoh N, Ueda S. Effects of Bupleurum scorzoneraefolium , Bupleurum falcatum , and saponins on nephrotoxic serum nephritis in mice. J Ethnopharmacol . 2008;116(3):397-402.
46. Ushio Y, Abe H. Inactivation of measles virus and herpes simplex virus by saikosaponin d. Planta Med . 1992;58(2):171-173.
47. Cheng PW, Ng LT, Chiang LC, Lin CC. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol . 2006;33(7):612-616.
48. Park KH, Park J, Koh D, Lim Y. Effect of saikosaponin-A, a triterpenoid glycoside, isolated from Bupleurum falcatum on experimental allergic asthma. Phytother Res . 2002;16(4):359-363.
48. Testai L, Silvio C, Ammar B, Luisa P, Vincenzo C, Martinotti E. Vasorelaxant effects of the chloroformic crude extract of Bupleurum fruticosum L. (Umbelliferae) roots on rat thoracic aorta. J Ethnopharmacol . 2005;96(1-2):93-97.
50. Kim SY, Yun-Choi HS. Platelet anti-aggregating activities of bupleurumin from the aerial parts of Bupleurum falcatum . Arch Pharm Res . 2007;30(5):561-564.
51. Aiba T, Takahashi T, Suzuki K, et al. Liver injury induced by a Japanese herbal medicine, sairei-to (TJ-114, Bupleurum and Hoelen Combination, Chai-Ling-Tang) R1. J Gastroenterol Hepatol . 2007;22(5):762-763.
52. Shiota Y, Wilson JG, Matsumoto H, et al. Adult respiratory distress syndrome induced by a Chinese medicine, Kamisyoyo-san. Intern Med . 1996;35(6):494-496.
Copyright © 2009 Wolters Kluwer Health